Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
Clinical Trial Heberbiovac HB vaccine Material Reference Batch
2011-05-16
Registered
NASVAC therapeutic vaccine study
2011-05-16
Registered
Heberprovac Study
2011-05-16
Registered
TS-FARMEV Study
2011-05-16
Registered
CERVISEG-300-I Study
2011-05-17
Registered
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study.
2011-04-28
Registered
CENTAURO Study
2011-04-29
Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months.
2011-04-29
Registered
NEUVITAL V Study
2011-04-30
Registered
Change in Manufacture Process of Heberbiovac HB vaccine.
2011-04-30
Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks.
2011-04-27
Registered
CIGB500 in healthy volunteers
2010-12-20
Registered
THERESA-2 Study
2010-12-20
Registered
THERESA
2008-10-07
Registered
Safety and immunogenicity of commercial Hepatitis B vaccines.
2009-02-27
Registered
Dynamic-I
2010-12-20
Registered
FarmaPEG-I
2008-10-07
Registered
Dermosep-I
2010-12-20
Registered
EPANEM-III
2010-12-20
Registered
AntiCEA M3-I
2010-12-20
Registered
« first
‹ previous
1
2
3
4
5
6
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform